AbbVie
ABBV
#30
Rank
C$635.16 B
Marketcap
C$359.50
Share price
4.20%
Change (1 day)
41.91%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$203.02 Billion

According to AbbVie's latest financial reports the company's total liabilities are C$203.02 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$187.87 B-0.66%
2024-12-31C$189.12 B14.7%
2023-12-31C$164.88 B-0.01%
2022-12-31C$164.89 B-1.3%
2021-12-31C$167.07 B-4.68%
2020-12-31C$175.28 B37.95%
2019-12-31C$127.06 B37.58%
2018-12-31C$92.35 B11.83%
2017-12-31C$82.58 B-0.01%
2016-12-31C$82.59 B21.26%
2015-12-31C$68.11 B127.77%
2014-12-31C$29.90 B13.72%
2013-12-31C$26.29 B11.85%
2012-12-31C$23.51 B204.59%
2011-12-31C$7.71 B42.18%
2010-12-31C$5.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$166.32 B-18.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$121.15 B-40.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$118.22 B-41.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.36 B-92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$46.60 B-77.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$94.18 B-53.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$94.54 B-53.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$85.40 B-57.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$2.12 B-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA